# BCS1L

## Overview
BCS1L is a gene that encodes the BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone, a mitochondrial inner membrane protein crucial for the assembly and function of mitochondrial complex III, a component of the electron transport chain. This protein is categorized as a mitochondrial AAA-ATPase, which plays a significant role in the import and assembly of the Rieske Iron-Sulfur protein (RISP), a subunit of complex III, in an ATP-dependent manner. The BCS1L protein is characterized by its unique structural features, including a heptameric arrangement and a distinct AAA ATPase domain, which facilitate its function in translocating substrates across the mitochondrial membrane. Mutations in the BCS1L gene are linked to several mitochondrial disorders, such as Björnstad syndrome and GRACILE syndrome, highlighting its critical role in maintaining mitochondrial function and integrity (Zhan2024Conformations; Tamai2008Characterization; Morán2010Cellular).

## Structure
The BCS1L protein is a membrane-bound oligomer that plays a crucial role in the translocation of the Rieske iron-sulfur protein precursor across the mitochondrial inner membrane, essential for the assembly of respiratory Complex III. Structurally, BCS1L consists of an N-terminal transmembrane (TM) segment, a middle Bcs1-specific domain, and a C-terminal AAA ATPase domain (Zhan2024Conformations). The protein forms a heptameric structure, deviating from the typical hexameric arrangement seen in most AAA proteins (Tang2020Structures).

The AAA ATPase domain of BCS1L includes a large RecA-like domain and a smaller helical domain, featuring a unique seven-stranded β-sheet, which is distinct from the five-stranded β-sheet found in other AAA proteins (Tang2020Structures). The Bcs1-specific domain is characterized by two β-sheets and two helices, forming a seven-bladed propeller structure (Xia2020Structural). This domain is crucial for the protein's function, potentially acting as a shutter to control substrate passage (Tang2020Structures).

BCS1L undergoes significant conformational changes upon nucleotide binding, transitioning between apo, ADP, and ATP-bound states, which influence its structural dynamics and function (Zhan2024Conformations). These changes are essential for its role in translocating substrates across the mitochondrial membrane.

## Function
The BCS1L gene encodes a mitochondrial inner membrane protein that plays a crucial role in the assembly and function of mitochondrial complex III, a component of the electron transport chain. This protein is involved in the import and assembly of the Rieske Iron-Sulfur protein (RISP), a subunit of complex III, facilitating its incorporation into the complex in an ATP-dependent manner (Tamai2008Characterization; Morán2010Cellular). BCS1L is essential for maintaining the stability and function of the respiratory chain complexes, particularly complex III, by stabilizing the RISP subunit and potentially aiding in the maturation of the Rieske subunit (Morán2010Cellular).

BCS1L interacts with the mitochondrial protein LETM1, contributing to the formation of mitochondrial tubular networks and the assembly of supercomplexes. This interaction is important for maintaining mitochondrial morphology and function, although LETM1 knockdown does not significantly affect the formation of the BCS1L complex (Tamai2008Characterization). In healthy cells, BCS1L is involved in the assembly of mitochondrial supercomplexes and maintaining mitochondrial network morphology, indicating its role in broader mitochondrial structural integrity (Morán2010Cellular). The protein's activity is localized to the inner mitochondrial membrane, where it interacts with the TOM mitochondrial import machinery for proper intramitochondrial sorting (Morán2010Cellular).

## Clinical Significance
Mutations in the BCS1L gene are associated with several mitochondrial disorders, primarily due to its role in the assembly of complex III of the mitochondrial electron transport chain. These disorders include Björnstad syndrome, GRACILE syndrome, and complex III deficiency. Björnstad syndrome is characterized by sensorineural hearing loss and pili torti, which are twisted hair shafts (Zhang2015Exome; Morán2010Cellular). GRACILE syndrome, often resulting from the homozygous p.S78G mutation, presents with symptoms such as growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death (Oláhová2019Molecular; Morán2010Cellular). Complex III deficiency can manifest as encephalopathy, tubulopathy, and hepatomegaly, with symptoms varying from mild to severe (De2003Clinical; Jackson2015A).

The clinical spectrum of BCS1L-related disorders is broad, with some patients exhibiting intermediate phenotypes that combine features of different syndromes, such as sensorineural deafness and renal tubulopathy (Oláhová2019Molecular). The variability in clinical presentations is attributed to the diverse mutations within the BCS1L gene, affecting its function and leading to mitochondrial dysfunction (Baker2018Clinical).

## Interactions
BCS1L, a mitochondrial AAA-ATPase, is involved in several critical protein interactions essential for the assembly and function of the mitochondrial respiratory chain. It interacts with the Rieske iron-sulfur protein (ISP), a subunit of Complex III, facilitating its translocation across the mitochondrial inner membrane. This interaction is ATP-dependent, with BCS1L undergoing conformational changes during ATP hydrolysis to assist in the translocation process (Zhan2024Conformations; Xia2020Structural).

BCS1L also interacts with LETM1, a mitochondrial protein involved in maintaining mitochondrial morphology. This interaction is crucial for the assembly of respiratory chain complexes I, III, and IV. The interaction between BCS1L and LETM1 is not dependent on ATP hydrolysis, as demonstrated by the ability of an ATPase-deficient BCS1L mutant to still interact with LETM1. Mutations in BCS1L, such as R155P, can disrupt this interaction, leading to deficiencies in complex III assembly (Tamai2008Characterization).

These interactions highlight BCS1L's role in maintaining mitochondrial function and structure, as well as its involvement in the biogenesis of respiratory chain complexes. The protein's ability to interact with multiple partners underscores its importance in cellular energy metabolism.


## References


[1. (De2003Clinical) Linda De Meirleir, Sara Seneca, Eliane Damis, Brigitte Sepulchre, Anne Hoorens, Erik Gerlo, M. Teres García Silva, Elena Martín Hernandez, Willy Lissens, and Rudy Van Coster. Clinical and diagnostic characteristics of complex iii deficiency due to mutations in the bcs1l gene. American Journal of Medical Genetics Part A, 121A(2):126–131, April 2003. URL: http://dx.doi.org/10.1002/ajmg.a.20171, doi:10.1002/ajmg.a.20171. This article has 79 citations.](https://doi.org/10.1002/ajmg.a.20171)

[2. (Tang2020Structures) Wai Kwan Tang, Mario J. Borgnia, Allen L. Hsu, Lothar Esser, Tara Fox, Natalia de Val, and Di Xia. Structures of aaa protein translocase bcs1 suggest translocation mechanism of a folded protein. Nature Structural &amp; Molecular Biology, 27(2):202–209, February 2020. URL: http://dx.doi.org/10.1038/s41594-020-0373-0, doi:10.1038/s41594-020-0373-0. This article has 36 citations.](https://doi.org/10.1038/s41594-020-0373-0)

[3. (Zhang2015Exome) Jie Zhang, Lina Duo, Zhimiao Lin, Huijun Wang, Jinghua Yin, Xu Cao, Jiahui Zhao, Lanlan Dai, Xuanzhu Liu, Jianguo Zhang, Yong Yang, and Zhanli Tang. Exome sequencing reveals novel bcs1l mutations in siblings with hearing loss and hypotrichosis. Gene, 566(1):84–88, July 2015. URL: http://dx.doi.org/10.1016/j.gene.2015.04.039, doi:10.1016/j.gene.2015.04.039. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2015.04.039)

[4. (Xia2020Structural) Di Xia. Structural snapshots of the cellular folded protein translocation machinery bcs1. The FEBS Journal, 288(9):2870–2883, October 2020. URL: http://dx.doi.org/10.1111/febs.15576, doi:10.1111/febs.15576. This article has 2 citations.](https://doi.org/10.1111/febs.15576)

[5. (Oláhová2019Molecular) Monika Oláhová, Camilla Ceccatelli Berti, Jack J Collier, Charlotte L Alston, Elisabeth Jameson, Simon A Jones, Noel Edwards, Langping He, Patrick F Chinnery, Rita Horvath, Paola Goffrini, Robert W Taylor, and John A Sayer. Molecular genetic investigations identify new clinical phenotypes associated with bcs1l-related mitochondrial disease. Human Molecular Genetics, 28(22):3766–3776, August 2019. URL: http://dx.doi.org/10.1093/hmg/ddz202, doi:10.1093/hmg/ddz202. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddz202)

[6. (Tamai2008Characterization) Shoko Tamai, Hiroshi Iida, Sadaki Yokota, Tomoko Sayano, Shoko Kiguchiya, Naotada Ishihara, Jun-Ichi Hayashi, Katsuyoshi Mihara, and Toshihiko Oka. Characterization of the mitochondrial protein letm1, which maintains the mitochondrial tubular shapes and interacts with the aaa-atpase bcs1l. Journal of Cell Science, 121(15):2588–2600, August 2008. URL: http://dx.doi.org/10.1242/jcs.026625, doi:10.1242/jcs.026625. This article has 107 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.026625)

[7. (Morán2010Cellular) María Morán, Lorena Marín-Buera, M. Carmen Gil-Borlado, Henry Rivera, Alberto Blázquez, Sara Seneca, María Vázquez-López, Joaquín Arenas, Miguel A. Martín, and Cristina Ugalde. Cellular pathophysiological consequences of bcs1l mutations in mitochondrial complex iii enzyme deficiency. Human Mutation, 31(8):930–941, June 2010. URL: http://dx.doi.org/10.1002/humu.21294, doi:10.1002/humu.21294. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21294)

[8. (Zhan2024Conformations) Jingyu Zhan, Allison Zeher, Rick Huang, Wai Kwan Tang, Lisa M. Jenkins, and Di Xia. Conformations of bcs1l undergoing atp hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate. Nature Communications, May 2024. URL: http://dx.doi.org/10.1038/s41467-024-49029-y, doi:10.1038/s41467-024-49029-y. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-49029-y)

[9. (Baker2018Clinical) Rachael A. Baker, Jessica R. C. Priestley, Amy M. Wilstermann, Kalina J. Reese, and Paul R. Mark. Clinical spectrum of bcs1l mitopathies and their underlying structural relationships. American Journal of Medical Genetics Part A, 179(3):373–380, December 2018. URL: http://dx.doi.org/10.1002/ajmg.a.61019, doi:10.1002/ajmg.a.61019. This article has 28 citations.](https://doi.org/10.1002/ajmg.a.61019)

[10. (Jackson2015A) C. B. Jackson, M. F. Bauer, A. Schaller, U. Kotzaeridou, A. Ferrarini, D. Hahn, H. Chehade, F. Barbey, C. Tran, S. Gallati, A. Haeberli, S. Eggimann, L. Bonafé, and J-M. Nuoffer. A novel mutation in bcs1l associated with deafness, tubulopathy, growth retardation and microcephaly. European Journal of Pediatrics, 175(4):517–525, November 2015. URL: http://dx.doi.org/10.1007/s00431-015-2661-y, doi:10.1007/s00431-015-2661-y. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00431-015-2661-y)